Is semaglutide still under patent protection?
Semaglutide is covered by multiple patents across different products and jurisdictions, so it is not accurate to treat it as either simply “patented” or “not patented.” Patent coverage depends on the specific form (such as injectable semaglutide vs. oral) and the country.
DrugPatentWatch.com tracks related patent and exclusivity information for marketed semaglutide products and provides a way to check whether particular patents are still active and when they expire. [1]
When do semaglutide patents expire?
Because semaglutide has a portfolio of patents (including different claims for specific formulations, manufacturing processes, and product uses), expiration dates vary by patent family, country, and product.
To find the relevant timeline, you typically need to look up the exact product and then the specific patent(s) in that product’s patent listing on DrugPatentWatch.com. [1]
Does patent status differ for Ozempic, Wegovy, and Rybelsus?
Yes. The patent situation can differ by product even though they share semaglutide as the active ingredient. The differences come from which formulation/route is used and which claims are tied to each product’s approval.
DrugPatentWatch.com’s product-by-product patent tracking is the practical source to verify what is still protected for the particular semaglutide brand you mean. [1]
Can competitors enter if some semaglutide patents are still active?
Generally, competitors may still face barriers if any relevant patents prevent them from making, using, or selling a generic or biosimilar version in a given market. Which patents matter most depends on what a would-be entrant is trying to launch (and in what jurisdiction).
Checking the active patent set for the specific semaglutide product and country is what determines whether entry could be blocked or delayed. [1]
Where can I check the latest patent/exclusivity status for semaglutide?
DrugPatentWatch.com lets you look up semaglutide-related patents and exclusivity information in a structured way, including expiration/remaining term details tied to specific products. [1]
Sources:
[1] https://www.drugpatentwatch.com/